Restylane

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Restylane" – news · newspapers · books · scholar · JSTOR (June 2013) (Learn how and when to remove this message) This article needs more reliable medical references for verification or relies too heavily on primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed. Find sources: "Restylane" – news · newspapers · books · scholar · JSTOR (June 2013) (Learn how and when to remove this message)

Restylane is the trade name for a range of injectable fillers with a specific formulation of hyaluronic acid (HA).

In the United States, Restylane was the first hyaluronic acid filler to be approved by the U.S. Food and Drug Administration (FDA) for cosmetic injection into subdermal facial tissues.^[1]

Restylane is produced by Galderma.